Abstract
The rapid increase in the spread of antibiotic resistance is one of the major problems of modern medicine. Of particular concern is the ESKAPE group of pathogens (E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, Enterobacter spp.), which possess the ability not only to evade the action of most antibacterial agents, but also to form persistent biofilms on abiotic and biotic surfaces. Given the current epidemiological profile of Ukraine, where the level of non­susceptibility to carbapenems among gram­negative pathogens is critical, there is a need to revise strategies for both targeted and empirical antibiotic therapy. This article is dedicated to analysing the common virulence mechanisms of ESKAPE pathogens and justifying the use of modern treatment regimens adapted to the evolutionary changes of these pathogens. Objective — to highlight the clinical and epidemiological significance of ESKAPE pathogens as leading factors in nosocomial infections and to justify the need to adapt antibiotic therapy strategies in the context of critically rising mortality rates. Materials and methods. A search for information sources was conducted in the Scopus, Web of Science, Google Scholar, PubMed, and UpToDate scientometric databases using keywords such as «ESKAPE pathogens», «nosocomial infections», «antibiotic resistance», «biofilm», «quorum sensing», and «A. baumannii, K. pneumoniae, S. aureus». Preference was given to information sources published from 2021 to 2026. Results and discussion. The analysis of the structure of nosocomial infections confirmed the dominance of the ESKAPE group, which accounts for 42.2—75.6 % of all cases of hospital­acquired infections, with A. baumannii, K. pneumoniae, and S. aureus predominating. The critical level of resistance of A. baumannii to carbapenems (82.1—94.5 %) indicates the ineffectiveness of most standard treatment regimens, and the high mortality rate (up to 70 %) necessitates a transition to reserve drugs. The list of drugs to which A. baumannii strains may retain susceptibility is extremely limited and includes either older highly toxic antibiotics (colistin, polymyxin B) or, in some cases, ampicillin/sulbactam, which can be used only in extremely high doses. Conclusions. ESKAPE pathogens are responsible for 42.2—75.6 % of cases of hospital­acquired bloodstream infections. Biofilm formation is the common evolutionary foundation for the persistence of ESKAPE pathogens. The most common pathogens among the ESKAPE group are A. baumannii, K. pneumoniae, and S. aureus. The critically high level of resistance of A. baumannii to carbapenems in Ukraine (82.1—94.5 %) makes the use of this group of drugs for the antibiotic therapy of nosocomial infections impossible. Given the current antibiotic resistance profile in Ukraine, colistin, polymyxin B, and ampicillin/sulbactam are the only available drugs for treating severe infections caused by A. baumannii.